Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$6.24+0.75 (+13.76%)
Close on Nov 20, 2026Market cap $116.75MP/E –Yield –
Trinity Biotech free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$6.02M. The highest annual figure on record is $20.58M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.02M | – |
| FY2024 | Dec 31, 2024 | -$4.60M | – |
| FY2023 | Dec 31, 2023 | -$12.36M | – |
| FY2022 | Dec 31, 2022 | -$2.02M | -117.7% |
| FY2021 | Dec 31, 2021 | $11.43M | -44.5% |
| FY2020 | Dec 31, 2020 | $20.58M | +523.7% |
| FY2019 | Dec 31, 2019 | $3.30M | – |
| FY2018 | Dec 31, 2018 | -$299.00K | -106.8% |
| FY2017 | Dec 31, 2017 | $4.41M | -26.6% |
| FY2016 | Dec 31, 2016 | $6.01M | -0.8% |
| FY2015 | Dec 31, 2015 | $6.06M | – |
See a number that looks wrong?